Sleep Disorders
News, opinions and meeting coverage in neurology.
<ѻýҕl>FDA Slashes Starting Dose for Lunestaѻýҕl>
SILVER SPRING, Md. -- Patients starting on the sleep drug eszopiclone (Lunesta) should take no more than 1 mg at bedtime -- one-third the current label-recommended dose -- because of the risk of next-day impairment, the FDA said Thursday.
May 15, 2014
<ѻýҕl>Murder: Another Ambien Side Effect?ѻýҕl>
NEW YORK CITY -- Forensic psychiatrists are facing new challenges with murders committed by people under the influence of the sleep drug zolpidem (Ambien) -- not least to persuade the criminal justice system to take their conclusions seriously.
May 07, 2014
<ѻýҕl>APA Meeting Highlights Mental Health Biologyѻýҕl>
NEW YORK CITY -- The biological basis for normal and abnormal mental function is emerging as a dominant theme in psychiatry research, and the American Psychiatric Association annual meeting that starts here Saturday won't be an exception.
May 01, 2014
<ѻýҕl>Common Cause for Bruxism, Restless Legs, Migraine?ѻýҕl>
NEW ORLEANS -- About half of patients with restless legs syndrome (RLS) seen in a single neurology practice also qualified for diagnoses of bruxism and migraine, suggesting a possible common cause for these disorders, a researcher said here.
Oct 17, 2013